Geneticure

Geneticure is a Mayo Clinic-backed pharmacogenomics (PGx) company leveraging genetic information to identify which anti-hypertension treatment is most likely to work for each patient based on their DNA. Geneticure takes a unique approach in PGx with its peer-reviewed clinical and health economic evidence and focuses on

Geneticure is active in the health & wellness space, founded in 2014.

Profile

Geneticure is a Mayo Clinic-backed pharmacogenomics (PGx) company leveraging genetic information to identify which anti-hypertension treatment is most likely to work for each patient based on their DNA. Geneticure takes a unique approach in PGx with its peer-reviewed clinical and health economic evidence and focuses on the genetics of integrative-physiology in chronic disease. Using a […]

Geneticure is positioned in health & wellness, a segment that rewards a clear, focused offering.

The company is listed at the Show HN launch stage of development.

Its team size is recorded as 11-50 employees.

Website: geneticure.com